安達維爾(300719.SZ):智能裝備研製業務,主要為航空航天與防務領域的研發生產單位,提供研發製造與裝備保障領域的智能技術解決方案
格隆匯3月28日丨安達維爾(300719.SZ)在投資者互動平台表示,公司智能裝備研製業務,主要為航空航天與防務領域的研發生產單位,提供研發製造與裝備保障領域的智能技術解決方案。工業軟件方面,公司已推出SIPDM超越集成產品研發管理信息系統,該產品是基於“集成產品開發(IPD)”與全特性產品開發的原則,而開發的產品研發管理軟件主要面向具備一定的研發管理體系和研發管理複雜程度的各類企業。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.